1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6044AF622F7E8A32A65257D8C0027F4DA
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/044AF622F7E8A32A65257D8C0027F4DA!OpenDocument
18
19OpenDocument
2034.207.230.188
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Business Operations Benchmarking and Quality Medical Affairs

Document Excerpt: Medical Affairs Excellence: Showing the Value of the Medical Affairs Function

DB Image

ID: MD-436


Features:

14 Info Graphics

18 Data Graphics

400+ Metrics


Pages/Slides: 4


Published: Pre-2016


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click
"Download Free Excerpt".


To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5333 "Medical Affairs Excellence: Showing the Value of the Medical Affairs Function."


Industries Profiled:
Pharmaceutical; Biotech; Health Care; Biopharmaceutical; Clinical Research; Laboratories; Manufacturing; Consumer Products; Diagnostic; Medical Device


Companies Profiled:
Astellas; UCB Pharma; Onyx Pharmaceuticals; Upsher-Smith; Medunik Canada; ViiV Healthcare; Purdue Pharma; Xenoport; Lilly; Sanofi; Insys Therapeutics; Theravance; Lundbeck; Bayer; Merck; Ipsen; Merz Pharma; Amgen; Janssen; Baxter BioScience; Jazz Pharmaceuticals; AstraZeneca; Biogen Idec; Axon Pharma; Boehringer Ingelheim; Eisai

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.